For critically ill patients with acute respiratory distress syndrome (ARDS) and other life-threatening conditions, starting advanced therapies such as extracorporeal membrane oxygenation (ECMO) earlier can potentially lead to better outcomes. Providence's ECMO program has been internationally recognized for multiple consecutive years as a Gold Center of Excellence by the Extracorporeal Life Support Organization (ELSO) due to the high-quality critical care we provide, and our survival rates are well above the national average.